GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: CNTO-1959 | Tremfya®
guselkumab is an approved drug (EMA & FDA (2017))
Compound class:
Antibody
Comment: Guselkumab is a monoclonal antibody directed against interleukin-23A (IL23A). It is being investigated as a treatment for plaque psoriasis.
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record. |
Classification ![]() |
|
| Compound class | Antibody |
| Approved drug? | Yes. EU EMA (2017) | US FDA (2017) |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 9774 | guselkumab |
Synonyms ![]() |
| CNTO-1959 | Tremfya® |
Database Links ![]() |
|
| Specialist databases | |
| IMGT/mAb-DB | 468 |
| Other databases | |
| GtoPdb PubChem SID | 249565678 |
| Search PubMed clinical trials | guselkumab |
| Search PubMed titles | guselkumab |
| Search PubMed titles/abstracts | guselkumab |
| Wikipedia | Guselkumab |